ArticleFrontiers in immunology2026
RNF213 marks a regulatory T-cell subset associated with ulcerative colitis.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ulcerative colitis (UC) is a nonspecific autoimmune disease, the etiology and pathogenesis of which remain unclear. Identifying new disease targets could inform clinical diagnosis and treatment. Methods: We integrated single-cell RNA sequencing (scRNA-seq) and bulk transcriptome data from UC patients. We screened key biomarkers and constructed a nomogram diagnostic model through three machine learning algorithms (LASSO, SVM-RFE, and Boruta). Results: Five UC-specific ubiquitination biomarkers were identified: ZC3H12A, ENC1, RNF213, MAP3K5, and RMND5A. Among them, RNF213 demonstrated superior diagnostic performance with an AUC greater than 0.9 in both training and validation cohorts. Single-cell localization and Conclusions: This study identifies RNF213 as a biomarker enriched in UC-associated mucosal Tregs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.